1. Home
  2. CGTX vs VNCE Comparison

CGTX vs VNCE Comparison

Compare CGTX & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • VNCE
  • Stock Information
  • Founded
  • CGTX 2007
  • VNCE 2002
  • Country
  • CGTX United States
  • VNCE United States
  • Employees
  • CGTX N/A
  • VNCE N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • CGTX Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • CGTX 23.1M
  • VNCE 20.2M
  • IPO Year
  • CGTX 2021
  • VNCE 2013
  • Fundamental
  • Price
  • CGTX $0.28
  • VNCE $1.58
  • Analyst Decision
  • CGTX Strong Buy
  • VNCE Strong Buy
  • Analyst Count
  • CGTX 5
  • VNCE 3
  • Target Price
  • CGTX $6.13
  • VNCE $4.33
  • AVG Volume (30 Days)
  • CGTX 692.0K
  • VNCE 36.0K
  • Earning Date
  • CGTX 05-07-2025
  • VNCE 06-17-2025
  • Dividend Yield
  • CGTX N/A
  • VNCE N/A
  • EPS Growth
  • CGTX N/A
  • VNCE N/A
  • EPS
  • CGTX N/A
  • VNCE N/A
  • Revenue
  • CGTX N/A
  • VNCE $293,452,000.00
  • Revenue This Year
  • CGTX N/A
  • VNCE N/A
  • Revenue Next Year
  • CGTX N/A
  • VNCE $5.81
  • P/E Ratio
  • CGTX N/A
  • VNCE N/A
  • Revenue Growth
  • CGTX N/A
  • VNCE 0.19
  • 52 Week Low
  • CGTX $0.31
  • VNCE $1.27
  • 52 Week High
  • CGTX $2.95
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 31.37
  • VNCE 42.84
  • Support Level
  • CGTX $0.40
  • VNCE $1.69
  • Resistance Level
  • CGTX $0.47
  • VNCE $2.49
  • Average True Range (ATR)
  • CGTX 0.03
  • VNCE 0.21
  • MACD
  • CGTX -0.01
  • VNCE 0.02
  • Stochastic Oscillator
  • CGTX 2.76
  • VNCE 8.33

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: